FBITX | RDITX | FBITX / RDITX | |
Total Expense Ratio | 0.46 | 0.72 | 64% |
Annual Report Gross Expense Ratio | 0.46 | 0.72 | 64% |
Fund Existence | 11 years | 18 years | - |
Gain YTD | 6.850 | 6.715 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 36.5B | 36.5B | 100% |
Annual Yield % from dividends | 1.21 | 0.96 | 126% |
Returns for 1 year | 10.15 | 9.84 | 103% |
Returns for 3 years | 39.14 | 38.43 | 102% |
Returns for 5 years | 47.71 | 46.54 | 103% |
Returns for 10 years | 73.84 | 72.41 | 102% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 77.13 | -0.37 | -0.48% |
T. Rowe Price Health Sciences | |||
WLCIX | 14.32 | -0.11 | -0.76% |
Allspring Large Company Value Inst | |||
SEQAX | 16.76 | -0.19 | -1.12% |
NAA World Equity Income A | |||
FCBSX | 33.01 | -0.46 | -1.37% |
Franklin Mutual U.S. Mid Cap Value C | |||
LISIX | 15.55 | -0.23 | -1.46% |
Lazard International Strategic Eq Instl |